This personalization ensures that patients receive focused support, whether it is for immune boosting, detoxification, anti-aging, or enhanced athletic performance
Phase 1 trial evaluating TTI-101, a first-in-class, orally bioavailable, small molecule, inhibitor of STAT3, in patients with advanced solid tumors
These modifications contribute to the morphological restructuring of cancer, including the compression of blood vessels, which may lead to impaired circulation and insufficient oxygen supply
They may include: Nausea Stomach cramps Bloating And Changes in bowel movements They happen due to poor absorption, high doses, or taking glutathione on an empty stomach